Kevan Clemens, Director at Chelsea Therapeutics International, Ltd. (CHTP), bought 5,000 shares at $2.85 ($14K) on 2008-10-03, disclosed to the SEC on 2008-10-03.
Open-market purchase of $14k CHTP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.